Cost, Quality, and Outcomes
Healthcare institutions understand that in order to deliver the best patient care possible, they will need to operate beyond the intersection of cost, quality, and outcomes. When choosing products for a hospital system, the focus is changing from “cost of product” to “cost of care.” That cost of care extends well beyond the surgery, to include the follow-up care, procedures, patients' return to their previous activities, and quality of life.
Economic Value and Mesh Selection for Hernia Repair
In hernia repair, the cost of the mesh or biomaterial selected is only the first consideration, but it is potentially very significant in determining value. For example, a biosynthetic product like GORE® BIO-A® Tissue Reinforcement can be less than half of the cost of biologic meshes. Even with biologics providing discounted contract pricing, there is a substantial cost savings that must be evaluated and considered as part of value analysis. GORE® BIO-A® Tissue Reinforcement is included in several contracts. Please check with your local Gore Sales Associate for even more potential savings.
Surgeons and industry leaders have identified the value of GORE® BIO-A® Tissue Reinforcement:
Losses were greatest in cases involving use of biologic mesh, which resulted in a median net financial loss of $8,370. Biologic mesh more than doubled the direct costs of incisional hernia repair compared with synthetic repair ($16,970 vs $7,590). 1
- Frangou C. Ventral hernia repairs a financial bust for hospitals? General Surgery News 2012;39(8):1,6.